000778927 000__ 03307cam\a2200469Ii\4500
000778927 001__ 778927
000778927 005__ 20230306142901.0
000778927 006__ m\\\\\o\\d\\\\\\\\
000778927 007__ cr\nn\nnnunnun
000778927 008__ 170110s2017\\\\ja\\\\\\o\\\\\000\0\eng\d
000778927 019__ $$a974651430$$a981019081$$a981817078
000778927 020__ $$a9784431560593$$q(electronic book)
000778927 020__ $$a4431560599$$q(electronic book)
000778927 020__ $$z9784431560579
000778927 0247_ $$a10.1007/978-4-431-56059-3$$2doi
000778927 035__ $$aSP(OCoLC)ocn967982013
000778927 035__ $$aSP(OCoLC)967982013$$z(OCoLC)974651430$$z(OCoLC)981019081$$z(OCoLC)981817078
000778927 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dIDEBK$$dGW5XE$$dN$T$$dOCLCF$$dUAB$$dNJR$$dYDX$$dUPM$$dOCLCO$$dIOG$$dOCLCO$$dVT2
000778927 049__ $$aISEA
000778927 050_4 $$aRC388.5
000778927 08204 $$a616.8/106$$223
000778927 24500 $$aCell therapy against cerebral stroke :$$bcomprehensive reviews for translational researches and clinical trials /$$cKiyohiro Houkin, Koji Abe, Satoshi Kuroda, editors.
000778927 264_1 $$aTokyo, Japan :$$bSpringer,$$c2017.
000778927 300__ $$a1 online resource (x, 156 pages) :$$billustrations.
000778927 336__ $$atext$$btxt$$2rdacontent
000778927 337__ $$acomputer$$bc$$2rdamedia
000778927 338__ $$aonline resource$$bcr$$2rdacarrier
000778927 347__ $$atext file$$bPDF$$2rda
000778927 5050_ $$aPart I. Optimal Cell Sources -- 1. Bone Marrow-Derived Mononuclear Cells -- 2. Mesenchymal Stem Cells / Bone Marrow Stromal Cells -- 3. Neural Stem Cells / Neuronal Progenitor Cells -- 4. iPS Cells / iN -- Part II. Translational Research -- 5. Cell Culture -- 6. Cell Dose, Timing and Route -- 7. Scaffold -- 8. Cell Tracking -- 9. Functional Bio-Imaging -- Part III. Clinical Trials -- 10. Review of Previous Clinical Trials and Guideline of Cell Therapy -- 11. Bone Marrow-Derived Mononuclear Cells -- 12. Mesenchymal Stem Cells.
000778927 506__ $$aAccess limited to authorized users.
000778927 520__ $$aThis book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke. Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity. Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy. The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan.
000778927 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 19, 2017).
000778927 650_0 $$aCerebrovascular disease$$xChemotherapy.
000778927 650_0 $$aCellular therapy.
000778927 7001_ $$aHoukin, Kiyohiro,$$eeditor.
000778927 7001_ $$aAbe, Koji,$$eeditor.
000778927 7001_ $$aKuroda, Satoshi,$$eeditor.
000778927 77608 $$iPrint version:$$z9784431560579
000778927 852__ $$bebk
000778927 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-4-431-56059-3$$zOnline Access$$91397441.1
000778927 909CO $$ooai:library.usi.edu:778927$$pGLOBAL_SET
000778927 980__ $$aEBOOK
000778927 980__ $$aBIB
000778927 982__ $$aEbook
000778927 983__ $$aOnline
000778927 994__ $$a92$$bISE